166 related articles for article (PubMed ID: 11682034)
1. Liver cancer risk is increased in patients with porphyria cutanea tarda in comparison to matched control patients with chronic liver disease.
Fracanzani AL; Taioli E; Sampietro M; Fatta E; Bertelli C; Fiorelli G; Fargion S
J Hepatol; 2001 Oct; 35(4):498-503. PubMed ID: 11682034
[TBL] [Abstract][Full Text] [Related]
2. High prevalence of hepatitis C virus type 1b in Italian patients with Porphyria cutanea tarda.
Sampietro M; Fracanzani AL; Corbetta N; Amato M; Mattioli M; Molteni V; Fiorelli G; Fargion S
Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):543-7. PubMed ID: 9513830
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus antibodies and liver disease in patients with porphyria cutanea tarda.
DeCastro M; Sánchez J; Herrera JF; Cháves A; Durán R; García-Buey L; García-Monzón C; Sequí J; Moreno-Otero R
Hepatology; 1993 Apr; 17(4):551-7. PubMed ID: 7682979
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association.
Fargion S; Piperno A; Cappellini MD; Sampietro M; Fracanzani AL; Romano R; Caldarelli R; Marcelli R; Vecchi L; Fiorelli G
Hepatology; 1992 Dec; 16(6):1322-6. PubMed ID: 1359994
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular carcinoma risk in patients with porphyria cutanea tarda.
Gisbert JP; García-Buey L; Alonso A; Rubio S; Hernández A; Pajares JM; García-Díez A; Moreno-Otero R
Eur J Gastroenterol Hepatol; 2004 Jul; 16(7):689-92. PubMed ID: 15201583
[TBL] [Abstract][Full Text] [Related]
6. Autoimmunity and HCV infection in porphyria cutanea tarda: a controlled study.
Stölzel U; Schuppan D; Tillmann HL; Manns MP; Tannapfel A; Doss MO; Zimmer T; Köstler E
Cell Mol Biol (Noisy-le-grand); 2002 Feb; 48(1):43-7. PubMed ID: 11929046
[TBL] [Abstract][Full Text] [Related]
7. [Hepatocellular carcinoma associated to porphyria cutanea tarda and hepatitis C virus infection without cirrhosis].
Moreno FJ; Santoyo J; Bondía JA; Suárez MA; Jiménez M; Fernández JL; Conde M; Marín R; Ribeiro M; Peláez JM; de la Fuente A
Rev Esp Enferm Dig; 1998 Jan; 90(1):48-50. PubMed ID: 9558946
[TBL] [Abstract][Full Text] [Related]
8. The prevalence of hepatitis C in patients with porphyria cutanea tarda in Stockholm, Sweden.
Linde Y; Harper P; Floderus Y; Ros AM
Acta Derm Venereol; 2005; 85(2):164-6. PubMed ID: 15823914
[TBL] [Abstract][Full Text] [Related]
9. Familial and sporadic porphyria cutanea tarda: clinical and biochemical features and risk factors in 152 patients.
Muñoz-Santos C; Guilabert A; Moreno N; To-Figueras J; Badenas C; Darwich E; Herrero C
Medicine (Baltimore); 2010 Mar; 89(2):69-74. PubMed ID: 20517178
[TBL] [Abstract][Full Text] [Related]
10. Porphyria cutanea tarda and liver disease. A retrospective analysis of 17 cases from a single centre and review of the literature.
Cassiman D; Vannoote J; Roelandts R; Libbrecht L; Roskams T; Van den Oord J; Fevery J; Garmyn M; Nevens F
Acta Gastroenterol Belg; 2008; 71(2):237-42. PubMed ID: 18720935
[TBL] [Abstract][Full Text] [Related]
11. Lack of association between porphyria cutanea tarda and alpha 1-antitrypsin deficiency.
Fargion S; Sergi C; Bissoli F; Fracanzani AL; Suigo E; Carazzone A; Roberto C; Cappellini MD; Fiorelli G
Eur J Gastroenterol Hepatol; 1996 Apr; 8(4):387-91. PubMed ID: 8781910
[TBL] [Abstract][Full Text] [Related]
12. Porphyria cutanea tarda increases risk of hepatocellular carcinoma and premature death: a nationwide cohort study.
Baravelli CM; Sandberg S; Aarsand AK; Tollånes MC
Orphanet J Rare Dis; 2019 Apr; 14(1):77. PubMed ID: 30944007
[TBL] [Abstract][Full Text] [Related]
13. [Role of the hemochromatosis gene in prophyria cutanea tarda. Prospective study of 56 cases].
Skowron F; Bérard F; Grézard P; Wolf F; Morel Y; Perrot H
Ann Dermatol Venereol; 2001 May; 128(5):600-4. PubMed ID: 11427792
[TBL] [Abstract][Full Text] [Related]
14. [Porphyria cutanea tarda, hemosiderosis and hepatocellular carcinoma: report of one case].
Whittle C; Hepp J; Armas R; Schultz M
Rev Med Chil; 2010 May; 138(5):581-5. PubMed ID: 20668813
[TBL] [Abstract][Full Text] [Related]
15. [Porphyria cutanea tarda, chronic liver disease caused by the C virus and hepatocarcinoma. Clinical case].
Armas R; Krause P; Wolff C
Rev Med Chil; 1994 Jan; 122(1):72-4. PubMed ID: 7915041
[TBL] [Abstract][Full Text] [Related]
16. [Porphyria cutanea tarda, hepatocarcinoma and hepatitis C virus infection].
Rodríguez Cuartero A; González Martínez F; Ceballos Torres A
An Med Interna; 1995 Oct; 12(10):517-8. PubMed ID: 8519952
[No Abstract] [Full Text] [Related]
17. [Role of hepatitis C virus in porphyria cutanea tarda hepatopathy].
Quecedo L; Costa J; Enríquez de Salamanca R
Med Clin (Barc); 1996 Mar; 106(9):321-4. PubMed ID: 8667696
[TBL] [Abstract][Full Text] [Related]
18. [Hepatitis C virus infection in patients with porphyria].
Wolff C; Armas R; Puig A; Krause P; Parraguez A
Rev Med Chil; 1994 Mar; 122(3):294-8. PubMed ID: 7528936
[TBL] [Abstract][Full Text] [Related]
19. Porphyria cutanea tarda and hepatitis C virus infection.
Tsukazaki N; Watanabe M; Irifune H
Br J Dermatol; 1998 Jun; 138(6):1015-7. PubMed ID: 9747364
[TBL] [Abstract][Full Text] [Related]
20. [A heavy drinker case of HCV-Ab positive porphyria cutanea tarda, followed by primary hepatocellular carcinoma].
Oguma T; Tsukada N; Miyamoto K; Okamura Y; Nagasu N; Yonei Y; Inagaki Y; Suzuki O; Kawamura Y; Kiryu Y; Osamura Y
Nihon Shokakibyo Gakkai Zasshi; 1996 Jul; 93(7):501-5. PubMed ID: 8803458
[No Abstract] [Full Text] [Related]
[Next] [New Search]
